CONSIDERATIONS TO KNOW ABOUT AZELAPRAG PEPTIDE

In December, BioAge declared a multi-12 months investigation collaboration with Novartis to determine and validate novel therapeutic targets with the intersection of growing old biology and training, combining BioAge's longitudinal human getting older datasets with Novartis experience in workout biology.If this doesn’t come about for a drug and a